mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.35 |
2e-09 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.33 |
9e-09 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-08 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-08 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-07 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-07 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-07 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |